Most Clicked StoriesMore >


Purdue Pharma withdraws FDA application for abuse-deterrent OxyContin drug

FDLI SmartBrief | Jul 01, 2015

Purdue Pharma has withdrawn its FDA application to market its reformulated OxyContin pain treatment because it needs additional time to evaluate and review its research information related to overdose, abuse, addiction and death risks of the medication. An FDA committee was originally scheduled to meet next week to assess whether the updated version could lessen abuse rates by pain patients. U.S. News & World Report (06/30)


FDA faces lawsuit related to Gilead's hepatitis C treatments

FDLI SmartBrief | Jun 30, 2015

Few states pursued GMO labeling laws in 2015

FDLI SmartBrief | Jun 25, 2015

U.S. to release 120 medtech classes from premarket requirements

FDLI SmartBrief | Jul 01, 2015

FDA-approved drug could help people with alcohol, cocaine addiction, study says

FDLI SmartBrief | Jun 29, 2015

EU panel backs approval of 10 drugs

FDLI SmartBrief | Jun 29, 2015

FDA to expedite review of Merrimack, Baxalta drug for pancreatic cancer

FDLI SmartBrief | Jun 26, 2015

Rise in poisoning cases prompts FDA to consider restrictions on liquid nicotine

FDLI SmartBrief | Jul 01, 2015

Health agency reports 54 cyclospora cases in Texas

FDLI SmartBrief | Jun 25, 2015

FDA clears sleep apnea system from SomnoMed

FDLI SmartBrief | Jun 26, 2015


Find FDLI SmartBrief Issues by Date:



FDLI News More >


Missed our Intro to Food Law and Regulation training course? Download the slides and audio recording!

FDLI SmartBrief | Jul 01, 2015

Attend FDLI's signature Advertising & Promotion Conference!

FDLI SmartBrief | Jul 01, 2015

What are the perks of FDLI membership?

FDLI SmartBrief | Jun 30, 2015

Attend FDLI's introductory-level course on tobacco law and regulation to get up to speed

FDLI SmartBrief | Jun 30, 2015

FDLI Policy Forum out now -- free download for members

FDLI SmartBrief | Jun 29, 2015




Sign up for FDLI SmartBrief



Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition. Learn more

Recent Poll view more polls


What affect do you think this year's media focus on imported drug, food and medical device product safety will have in 2010?

Chart.